GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Erech Finance Cahalacha Ltd (XTAE:EFNC) » Definitions » Equity-to-Asset

Erech Finance Cahalacha (XTAE:EFNC) Equity-to-Asset : 0.19 (As of Dec. 2023)


View and export this data going back to 2010. Start your Free Trial

What is Erech Finance Cahalacha Equity-to-Asset?

Equity to Asset ratio is calculated as total stockholders equity divided by total asset. Erech Finance Cahalacha's Total Stockholders Equity for the quarter that ended in Dec. 2023 was ₪4.33 Mil. Erech Finance Cahalacha's Total Assets for the quarter that ended in Dec. 2023 was ₪23.47 Mil. Therefore, Erech Finance Cahalacha's Equity to Asset Ratio for the quarter that ended in Dec. 2023 was 0.19.

The historical rank and industry rank for Erech Finance Cahalacha's Equity-to-Asset or its related term are showing as below:

XTAE:EFNC' s Equity-to-Asset Range Over the Past 10 Years
Min: -0.19   Med: 0.3   Max: 0.51
Current: 0.19

During the past 11 years, the highest Equity to Asset Ratio of Erech Finance Cahalacha was 0.51. The lowest was -0.19. And the median was 0.30.

XTAE:EFNC's Equity-to-Asset is ranked worse than
88.12% of 867 companies
in the Medical Devices & Instruments industry
Industry Median: 0.64 vs XTAE:EFNC: 0.19

Erech Finance Cahalacha Equity-to-Asset Historical Data

The historical data trend for Erech Finance Cahalacha's Equity-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Erech Finance Cahalacha Equity-to-Asset Chart

Erech Finance Cahalacha Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Equity-to-Asset
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.20 0.42 0.51 0.42 0.19

Erech Finance Cahalacha Semi-Annual Data
Dec13 Dec14 Dec15 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Equity-to-Asset Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.51 0.42 0.42 0.48 0.19

Competitive Comparison of Erech Finance Cahalacha's Equity-to-Asset

For the Medical Devices subindustry, Erech Finance Cahalacha's Equity-to-Asset, along with its competitors' market caps and Equity-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Erech Finance Cahalacha's Equity-to-Asset Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Erech Finance Cahalacha's Equity-to-Asset distribution charts can be found below:

* The bar in red indicates where Erech Finance Cahalacha's Equity-to-Asset falls into.



Erech Finance Cahalacha Equity-to-Asset Calculation

Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.

Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.

Erech Finance Cahalacha's Equity to Asset Ratio for the fiscal year that ended in Dec. 2023 is calculated as

Equity to Asset (A: Dec. 2023 )=Total Stockholders Equity/Total Assets
=4.333/23.472
=0.18

Erech Finance Cahalacha's Equity to Asset Ratio for the quarter that ended in Dec. 2023 is calculated as

Equity to Asset (Q: Dec. 2023 )=Total Stockholders Equity/Total Assets
=4.333/23.472
=0.18

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Erech Finance Cahalacha  (XTAE:EFNC) Equity-to-Asset Explanation

Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.

For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.


Erech Finance Cahalacha Equity-to-Asset Related Terms

Thank you for viewing the detailed overview of Erech Finance Cahalacha's Equity-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.


Erech Finance Cahalacha (XTAE:EFNC) Business Description

Traded in Other Exchanges
N/A
Address
Yakov Eliav 5, Downtown, Jerusalem, ISR
Erech Finance Cahalacha Ltd, formerly Insuline Medical Ltd is a medical device company. It develops & markets technologies to the clinical effectiveness of devices & drugs for the treatment of diabetes. Its products include the InsuPatch device for insulin pump users, & the InsuPad device for injection users. The InsuPad is a company's flagship product.

Erech Finance Cahalacha (XTAE:EFNC) Headlines

No Headlines